Position in LIVN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,642,729
-$33,905 QoQ
Shares Held
88,778
-3.8% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LIVN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026NORDEA INVESTMENT MANAGEMENT AB holds $915,381,867 across 15 Medical Devices names. LIVN ranks #10 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
785,076 | $257,968,120 | |
| 2 | EW |
Edwards Lifesciences Corp
|
2,024,887 | $162,152,949 | |
| 3 | PODD |
Insulet Corp
|
557,290 | $116,941,732 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
1,401,293 | $99,744,035 | |
| 5 | BSX |
Boston Scientific Corp
|
1,330,037 | $83,459,821 | |
| 6 | MDT |
Medtronic plc
|
951,594 | $82,455,618 | |
| 7 | ABT |
Abbott Laboratories
|
616,182 | $63,263,405 | |
| 8 | DXCM |
Dexcom Inc
|
266,786 | $16,754,160 |
All Filings in LIVN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,642,729 | 88,778 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,676,634 | 92,258 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $5,511,056 | 105,213 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $4,648,944 | 103,264 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $3,961,859 | 100,862 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,182,004 | 68,711 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $2,954,900 | 56,241 | Shares | Sole | 2024-11-05 | |
| No filing history on record for this holder in this stock. | ||||||